Eli Lilly has hiked the price of popular weight loss injections. The pharmaceutical giant, which manufactures the active ...

Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

Eli Lilly has entered into a deal worth up to $1.3 billion with drug discovery company Superluminal Medicines to advance ...

Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line ...

The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...

Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to ...

CRISPR Therapeutics advances with promising CTX310 data and key clinical milestones ahead. Click here to read an analysis of ...

Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and ...

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

Clinicians should ask patients if they’re experiencing ‘diabetes device distress’ and help guide them through it.

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...